Potentiation of tumor formation by topical administration of 15-deoxy-Δ12,14-prostaglandin J2 in a model of skin carcinogenesis

Carcinogenesis

Volumn 27, Issue 2, 2006, Pages 328-336

  Millán, Olga ^a,b   Rico, Daniel ^a,b   Peinado, Héctor ^a   Zarich, Natasha ^c   Stamatakis, Konstantinos ^d   Pérez Sala, Dolores ^d   Rojas, José M ^c   Cano, Amparo ^a   Boscá, Lisardo ^a,b  

^a CSIC   (Spain)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 7,12 DIMETHYLBENZ[A]ANTHRACENE; CYCLOOXYGENASE 2; CYCLOPENTENONE DERIVATIVE; PHORBOL 13 ACETATE 12 MYRISTATE; RAS PROTEIN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL ADHESION; CELL COUNT; CELL LINE; CELL SIZE; CELL VIABILITY; CONTROLLED STUDY; FEMALE; GROWTH RATE; KERATINOCYTE; MALIGNANT TRANSFORMATION; METABOLITE; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SKIN CARCINOGENESIS; SKIN CARCINOMA; TISSUE SECTION; TUMOR VASCULARIZATION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ADMINISTRATION, TOPICAL; ANIMALS; APOPTOSIS; BIOLOGICAL RESPONSE MODIFIERS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; CYCLOOXYGENASE 2; DISEASE PROGRESSION; DRUG INTERACTIONS; FEMALE; KERATINOCYTES; MICE; PAPILLOMA; PROSTAGLANDIN D2; SKIN NEOPLASMS;

EID: 31544451531     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi213     Document Type: Article

References (46)

1. Fuchs,E. and Raghavan,S. (2002) Getting under the skin of epidermal morphogenesis. Nat. Rev. Genet., 3, 199-209.
2. Booth,C., Brady,G. and Potten,C.S. (2002) Crowd control in the crypt. Nat. Med., 8, 1360-1361.
3. Perez-Losada,J. and Balmain,A. (2003) Stem-cell hierarchy in skin cancer. Nat. Rev. Cancer, 3, 434-443.
4. Hennings,H. and Yuspa,S.H. (1985) Two-stage tumor promotion in mouse skin: An alternative interpretation. J. Natl. Cancer Inst., 74, 735-740.
5. Budunova,I.V., Perez,P., Vaden,V.R., Spiegelman,V.S., Slaga,T.J. and Jorcano,J.L. (1999) Increased expression of p50-NF-kB and constitutive activation of NF-kB transcription factors during mouse skin carcinogenesis. Oncogene, 18, 7423-7431.
6. Balmain,A., Ramsden,M., Bowden,G.T. and Smith,J. (1984) Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas. Nature, 307, 658-660.
7. Quintanilla,M., Brown,K., Ramsden,M. and Balmain,A. (1986) Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature, 322, 78-80.
8. Lazarov,M., Kubo,Y., Cai,T., Dajee,M., Tarutani,M., Lin,Q., Fang,M., Tao,S., Green,C.L. and Khavari,P.A. (2002) CDK4 coexpression with Ras generates malignant human epidermal tumorigenesis. Nat. Med., 8, 1105-1114.
9. Cano,A., Gamallo,C., Kemp,C.J., Benito,N., Palacios,J., Quintanilla,M. and Balmain,A. (1996) Expression pattern of the cell adhesion molecules. E-cadherin, P-cadherin and a6β4 intergrin is altered in pre-malignant skin tumors of p53-deficient mice. Int. J. Cancer, 65, 254-262.
10. Hennings,H., Shores,R., Mitchell,P., Spangler,E.F. and Yuspa,S.H. (1985) Induction of papillomas with a high probability of conversion to malignancy. Carcinogenesis, 6, 1607-1610.
11. Furstenberger,G., Marks,F. and Muller-Decker,K. (2003) Cyclooxygenase-2 and skin carcinogenesis. Prog. Exp. Tumor Res., 37, 72-89.
12. Tripp,C.S., Blomme,E.A., Chinn,K.S., Hardy,M.M., LaCelle,P. and Pentland,A.P. (2003) Epidermal COX-2 induction following ultraviolet irradiation: Suggested mechanism for the role of COX-2 inhibition in photoprotection. J. Invest. Dermatol., 121, 853-861.
13. Fischer,S.M., Conti,C.J., Viner,J., Aldaz,C.M. and Lubet,R.A. (2003) Celecoxib and difluoromethylornithine in combination have strong therapeutic activity against UV-induced skin tumors in mice. Carcinogenesis, 24, 945-952.
14. Minter,H.A., Eveson,J.W., Huntley,S., Elder,D.J. and Hague,A. (2003) The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis. Clin. Cancer Res., 9, 1885-1897.
15. Tiano,H.F., Loftin,C.D., Akunda,J. et al. (2002) Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis. Cancer Res., 62, 3395-3401.
16. Tang,Q., Chen,W., Gonzales,M.S., Finch,J., Inoue,H. and Bowden,G.T. (2001) Role of cyclic AMP responsive element in the UVB induction of cyclooxygenase-2 transcription in human keratinocytes. Oncogene, 20, 5164-5172.
17. Chen,W., Tang,Q., Gonzales,M.S. and Bowden,G.T. (2001) Role of p38 MAP kinases and ERK in mediating ultraviolet-B induced cyclooxygenase-2 gene expression in human keratinocytes. Oncogene, 20, 3921-3926.
18. Tang,Q., Gonzales,M., Inoue,H. and Bowden,G.T. (2001) Roles of Akt and glycogen synthase kinase 3β in the ultraviolet B induction of cyclooxygenase-2 transcription in human keratinocytes. Cancer Res., 61, 4329-4332.
19. Konger,R.L., Scott,G.A., Landt,Y., Ladenson,J.H. and Pentland,A.P. (2002) Loss of the EP2 prostaglandin E2 receptor in immortalized human keratinocytes results in increased invasiveness and decreased paxillin expression. Am. J. Pathol., 161, 2065-2078.
20. Akunda,J.K., Lao,H.C., Lee,C.A., Sessoms,A.R., Slade,R.M. and Langenbach,R. (2004) Genetic deficiency or pharmacological inhibition of cyclooxygenase-1 or -2 induces mouse keratinocyte differentiation in vitro and in vivo. FASEB J., 18, 185-187.
21. Bachelor,M.A., Silvers,A.L. and Bowden,G.T. (2002) The role of p38 in UVA-induced cyclooxygenase-2 expression in the human keratinocyte cell line, HaCaT. Oncogene, 21, 7092-7099.
22. 2 binds to and activates H-Ras. Proc. Natl Acad. Sci. USA, 100, 4772-4777.
23. Moore,R.J., Owens,D.M., Stamp,G. et al. (1999) Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis. Nat. Med., 5, 828-831.
24. Olmeda,D., Castel,S., Vilaro,S. and Cano,A. (2003) β-catenin regulation during the cell cycle: Implications in G2/M and apoptosis. Mol. Biol. Cell, 14, 2844-2860.
25. Iglesias,M., Frontelo,P., Gamallo,C. and Quintanilla,M. (2000) Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas. Oncogene, 19, 4134-4145.
26. Santibanez,J.F., Frontelo,P., Iglesias,M., Martinez,J. and Quintanilla,M. (1999) Urokinase expression and binding activity associated with the transforming growth factor β1-induced migratory and invasive phenotype of mouse epidermal keratinocytes. J. Cell Biochem., 74, 61-73.
27. Hortelano,S., Traves,P.G., Zeini,M., Alvarez,A.M. and Bosca,L. (2003) Sustained nitric oxide delivery delays nitric oxide-dependent apoptosis in macrophages: Contribution to the physiological function of activated macrophages. J. Immunol., 171, 6059-6064.
28. Millan,O., Ballester,A., Castrillo,A., Oliva,J.L., Traves,P.G., Rojas,J.M. and Bosca,L. (2003) H-Ras-specific activation of NF-kB protects NIH 3T3 cells against stimulus-dependent apoptosis. Oncogene, 22, 477-483.
29. Jorge,R., Zarich,N., Oliva,J.L., Azanedo,M., Martinez,N., de la Cruz,X. and Rojas,J.M. (2002) HSos1 contains a new amino-terminal regulatory motif with specific binding affinity for its pleckstrin homology domain. J. Biol. Chem., 277, 44171-44179.
30. Hortelano,S., Zeini,M., Castrillo,A., Alvarez,A.M. and Bosca,L. (2002) Induction of apoptosis by nitric oxide in macrophages is independent of apoptotic volume decrease. Cell Death. Differ., 9, 643-650.
31. Moos,P.J., Edes,K., Cassidy,P., Massuda,E. and Fitzpatrick,F.A. (2003) Electrophilic prostaglandins and lipid aldehydes repress redox-sensitive transcription factors p53 and hypoxia-inducible factor by impairing the selenoprotein thioredoxin reductase. J. Biol. Chem., 278, 745-750.
32. 2: The endogenous electrophile that induces neuronal apoptosis. Proc. Natl. Acad. Sci. USA, 99, 7367-7372.
33. Downward,J. (2004) PI 3-kinase, Akt and cell survival. Semin. Cell Dev. Biol., 15, 177-182.
34. Downward,J. (2003) Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer, 3, 11-22.
35. Khwaja,A., Rodriguez-Viciana,P., Wennstrom,S., Wame,P.H. and Downward,J. (1997) Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J., 16, 2783-2793.
36. Fischer,S.M. (2002) Is cyclooxygenase-2 important in skin carcinogenesis? J. Environ. Pathol. Toxicol. Oncol., 21, 183-191.
37. Higashi,Y., Kanekura,T. and Kanzaki,T. (2000) Enhanced expression of cyclooxygenase (COX)-2 in human skin epidermal cancer cells: Evidence for growth suppression by inhibiting COX-2 expression. Int. J. Cancer, 86, 667-671.
38. Tsujii,M., Kawano,S., Tsuji,S., Sawaoka,H., Hori,M. and DuBois,R.N. (1998) Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93, 705-716.
39. Williams,C.S., Watson,A.J., Sheng,H., Helou,R., Shao,J. and DuBois,R.N. (2000) Celecoxib prevents tumor growth in vivo without toxicity to normal gut: Lack of correlation between in vitro and in vivo models. Cancer Res., 60, 6045-6051.
40. Williams,C.S., Tsujii,M., Reese,J., Dey,S.K. and DuBois,R.N. (2000) Host cyclooxygenase-2 modulates carcinoma growth. J. Clin. Invest., 105, 1589-1594.
41. Muller-Decker,K., Neufang,G., Berger,J., Neumann,M., Marks,F. and Furstenberger,G. (2002) Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis. Proc. Natl Acad. Sci. USA, 99, 12483-12488.
42. Nishihara,H., Kizaka-Kondoh,S., Insel,P.A. and Eckmann,L. (2003) Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein (IAP)-2. Proc. Natl Acad. Sci. USA, 100, 8921-8926.
43. Han,J.A., Kim,J.I., Ongusaha,P.P., Hwang,D.H., Ballou,L.R., Mahale,A., Aaronson,S.A. and Lee,S.W. (2002) P53-mediated induction of Cox-2 counteracts p53-or genotoxic, stress-induced apoptosis. EMBO J., 21, 5635-5644.
44. 2, and the ligation of PPAR-γ. J. Clin. Invest., 112, 945-955.
45. 2 brings about acute inflammatory resolution in rat pleurisy by inducing neutrophil and macrophage apoptosis. FASEB J., 17, 2269-2271.
46. Gilroy,D.W., Colville-Nash,P.R., Willis,D., Chivers,J., Paul-ClarkM.J. and Willoughby,D.A. (1999) Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med., 5, 698-701.